Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.22% |
| 2 | Technology | 18.11% |
| 3 | Financials | 7.1% |
| 4 | Communication Services | 5.53% |
| 5 | Consumer Discretionary | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3801
Bakkt Inc
BKKT
$347M
| $146K | ﹤0.01% |
19,838
-2,507
| -11% | -$29.7K |
2024 Q3
6 quarters
|
|
3802
State Street SPDR S&P Global Dividend ETF
WDIV
$275M
| $145K | ﹤0.01% |
+1,880
| New | +$148K |
2026 Q1
0 quarters
|
|
|
LMRI
3803
Lumexa Imaging Holdings
LMRI
$970M
| $145K | ﹤0.01% |
16,847
+9,647
| +134% | +$132K |
2025 Q4
1 quarter
|
|
3804
Geospace Technologies
GEOS
$61.7M
| $145K | ﹤0.01% |
11,866
-11,478
| -49% | -$160K |
2023 Q3
10 quarters
|
|
3805
Kaltura
KLTR
$195M
| $145K | ﹤0.01% |
118,654
-126,640
| -52% | -$180K |
2022 Q3
14 quarters
|
|
3806
Plumas Bancorp
PLBC
$429M
| $145K | ﹤0.01% |
2,965
-8,151
| -73% | -$402K |
2023 Q1
12 quarters
|
|
3807
Peoples Bancorp of North Carolina
PEBK
$230M
| $144K | ﹤0.01% |
3,684
-6,173
| -63% | -$232K |
2023 Q3
10 quarters
|
|
|
TSSI
3808
TSS Inc
TSSI
$278M
| $144K | ﹤0.01% |
11,086
-21,831
| -66% | -$220K |
2025 Q2
3 quarters
|
|
3809
Carter Bankshares
CARE
$703M
| $144K | ﹤0.01% |
6,176
-28,726
| -82% | -$599K |
2022 Q1
16 quarters
|
|
|
SBDS
3810
DELISTED
Solo Brands Inc
SBDS
| $144K | ﹤0.01% |
38,297
| – | – |
2025 Q3
2 quarters
|
|
|
COHX
3811
Tradr 2X Long COHR Daily ETF
COHX
$71.7M
| $144K | ﹤0.01% |
+5,750
| New | +$177K |
2026 Q1
0 quarters
|
|
3812
Zevra Therapeutics
ZVRA
$605M
| $144K | ﹤0.01% |
15,445
-84,690
| -85% | -$763K |
2022 Q3
14 quarters
|
|
3813
Sagimet Biosciences
SGMT
$582M
| $143K | ﹤0.01% |
27,429
-1,909
| -7% | -$10.6K |
2025 Q3
2 quarters
|
|
3814
Black Diamond Therapeutics
BDTX
$108M
| $143K | ﹤0.01% |
67,279
-7,531
| -10% | -$17.9K |
2022 Q1
16 quarters
|
|
3815
Daily Journal
DJCO
$900M
| $143K | ﹤0.01% |
297
-1,669
| -85% | -$913K |
2017 Q1
36 quarters
|
|
3816
Daktronics
DAKT
$847M
| $143K | ﹤0.01% |
7,327
-52,965
| -88% | -$1.21M |
2013 Q2
51 quarters
|
|
3817
FerroAtlántica
GSM
$762M
| $143K | ﹤0.01% |
34,719
-154,805
| -82% | -$746K |
2025 Q1
4 quarters
|
|
3818
Wabash National
WNC
$508M
| $143K | ﹤0.01% |
16,544
-54,349
| -77% | -$540K |
2013 Q2
51 quarters
|
|
3819
BrightSpring Health Services Unit
BTSGU
$1.5B
| $142K | ﹤0.01% |
1,000
-31,816
| -97% | -$4.3M |
2024 Q1
8 quarters
|
|
3820
Riley Exploration Permian
REPX
$910M
| $142K | ﹤0.01% |
3,888
-19,289
| -83% | -$574K |
2022 Q1
16 quarters
|
|
3821
Vishay Precision Group
VPG
$1B
| $142K | ﹤0.01% |
3,263
-15,391
| -83% | -$695K |
2016 Q1
40 quarters
|
|
3822
NerdWallet
NRDS
$548M
| $141K | ﹤0.01% |
13,630
-71,966
| -84% | -$810K |
2022 Q2
15 quarters
|
|
|
CEPU
3823
Central Puerto
CEPU
$1.77B
| $141K | ﹤0.01% |
+8,400
| New | +$133K |
2026 Q1
0 quarters
|
|
3824
Achieve Life Sciences
ACHV
$775M
| $141K | ﹤0.01% |
48,067
-61,965
| -56% | -$275K |
2024 Q2
7 quarters
|
|
|
OCTM
3825
FT Vest U.S. Equity Max Buffer ETF - October
OCTM
$31.7M
| $141K | ﹤0.01% |
4,341
-554
| -11% | -$18.1K |
2024 Q4
5 quarters
|
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $42.4B of net new capital in Q1 2026, opening 397 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 397 new positions and closed 563 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.